Europe Pharmaceutical Isolator Market to Grow at a CAGR of 8.7% to reach US$ 3,114.23 million by 2028 Million from 2021 to 2028

Europe Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Configuration (Floor Standing, Modular, Mobile, and Compact), Application (Aseptic Isolators, Containment Isolators, Sampling and Weighing Isolators, Fluid Dispensing Isolators, and Others), and End User (Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Laboratories, and Others)

Publication Month : Nov 2021

  • Report Code : TIPRE00025884
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 158
Inquire Before Buy

PRICING

$3000

$1800

The Europe pharmaceutical isolator market is expected to grow from US$ 1,741.57 million in 2021 to US$ 3,114.23 million by 2028; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028.



The UK, Germany, France, Italy, and Spain are major economies in Europe. Rules and regulations to support adoption of pharmaceutical isolators is expected to surge the market growth. A pharmaceutical isolator offers a superior sterile environment than conventional clean rooms. Positive or negative pressures inside the chamber prevent contamination due to operator interference. It ensures long-lasting sterility in accordance with pharmaceutical regulations related to the manufacturing of sterile medicine products. Moreover, most of the experts agree that regulatory agencies are no longer impeding progress when it comes to technologies such as pharmaceutical isolators. The guidelines set by the agencies have an important role in the adoption of isolators in comparison to cleanrooms. Administrations mentions isolators 55 times in its latest guideline of manufacturing in an aseptic environment. A well-designed positive pressure isolator, supported by adequate procedures for its maintenance, monitoring, and controls, offers significant advantages over traditional aseptic processing, including fewer opportunities for microbial contamination during processing. Isolators have become a core component of the pharmaceutical industry, as the cost of noncompliance with the regulatory guidelines is much high. Pharmaceutical isolators are critical for a range of processes to ensure aseptic conditions and containment. Stringent aseptic conditions are essential to maintain quality control and meet the administration current good manufacturing practice guidelines and other regulatory demands. WHO good manufacturing practices guidelines for sterile pharmaceutical products, section 8 of Annex 6 also mention the use of isolator technology to minimize human interventions in processing areas. All these regulatory guidelines fuel the adoption of pharmaceutical isolators in the Europe market.

In case of COVID-19, Europe is highly affected specially France and Russia. Europe has strengthened its efforts to serve through its pharmaceutical industry. For instance, On January 4, 2021, Moderna and Recipharm Announce COVID-19 vaccine supply agreement. The companies have entered into an agreement to support the formulation and fill/finish of Moderna’s COVID-19 vaccine supply outside of the United States. According to a Recipharm press release, the manufacturing will take place at Recipharm’s drug product manufacturing facility in France and, subject to regulatory approval in countries outside of the US, the supply will begin in early 2021. On December 9, 2020, CureVac N.V, a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Fareva announced an agreement regarding the fill & finish manufacturing of CureVac´s COVID-19 vaccine candidate, CVnCoV, at Fareva’s Pau and Val-de-Reuil-sites in France. Wockhardt Ltd has entered into an agreement with the UK government to fill and finish covid-19 vaccine vials at its subsidiary CP Pharmaceuticals’ facility based in Wrexham, North Wales. As per the agreement, Wockhardt will fill finish the vaccines in vials after it receives the bulk products from the company manufacturing successful vaccines. All these developments will support the market growth for pharmaceutical isolators during the pandemic.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe pharmaceutical isolator market. The Europe pharmaceutical isolator market is expected to grow at a good CAGR during the forecast period.
Europe pharmaceutical isolator market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Europe Pharmaceutical Isolator Market Segmentation   

Europe Pharmaceutical Isolator Market – By Type

  • Open Isolators
  • Closed Isolators

Europe Pharmaceutical Isolator Market – By Pressure

  • Positive Pressure
  • Negative Pressure

Europe Pharmaceutical Isolator Market – By Configuration

  • Floor Standing
  • Modular
  • Compact
  • Mobile

Europe Pharmaceutical Isolator Market – By Application

  • Aseptic
  • Sampling & Weighing
  • Fluid Dispensing
  • Containment    
  • Others

Europe Pharmaceutical Isolator Market – By End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals
  • Research and Academic Laboratories
  • Other

Europe Pharmaceutical Isolator Market, by Country

  • Germany  
  • France
  • Italy
  • UK 
  • Spain
  • Rest of Europe

Europe Pharmaceutical Isolator Market -Companies Mentioned

  • Azbil Telstar
  • Bioquell (Ecolab Solution)
  • Comecer
  • Fedegari Autoclavi S.p.A.
  • Getinge AB
  • Hosokawa Micron Group
  • ITECO S.R.L.
  • Nuaire Inc.
  • Schematic Engineering Industries
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

  1. Azbil Telstar
  2. Bioquell (Ecolab Solution)
  3. Comecer
  4. Fedegari Autoclavi S.p.A.
  5. Getinge AB
  6. Hosokawa Micron Group
  7. ITECO S.R.L.
  8. Nuaire Inc.
  9. Schematic Engineering Industries

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Europe Pharmaceutical Isolator Market